Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11020382 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Patent 11020382 was granted and assigned to Global Blood Therapeutics on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+260 characters)
Article

Patent abstract

Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.

Edits on 10 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 10 Oct, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Athiwat Hutchaleelaha0
Eleanor L. Ramos0
Joshua Eli Lehrer-Graiwer0
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110203820
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 5 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 5 Apr, 2023
Edits on 4 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Global Blood Therapeutics
Global Blood Therapeutics
0
Current Assignee
Global Blood Therapeutics
Global Blood Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110203820
Date of Patent
June 1, 2021
0
Patent Application Number
153681420
Date Filed
December 2, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110203820
Patent Citations
‌
US Patent 10004725 Methods of treatment
0
‌
US Patent 10017491 Compounds and uses thereof for the modulation of hemoglobin
0
‌
US Patent 10034879 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
0
‌
US Patent 10077249 Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
0
‌
US Patent 10137118 Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
0
‌
US Patent 10450269 Compounds and uses thereof for the modulation of hemoglobin
0
‌
US Patent 10683285 Modulators of hemoglobin
0
Patent Primary Examiner
‌
Jean P Cornet
0
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11020382
Edits on 12 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 12 Feb, 2022
Edits made to:
Infobox (+16 properties)
‌

 US Patent 11020382 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Infobox
Is a
Patent
Patent
Patent applicant
Global Blood Therapeutics
Global Blood Therapeutics
Current assignee
Global Blood Therapeutics
Global Blood Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11020382
Date of patent
June 1, 2021
Patent application number
15368142
Date Filed
December 2, 2016
Patent citations
‌
US Patent 10004725 Methods of treatment
‌
US Patent 10017491 Compounds and uses thereof for the modulation of hemoglobin
‌
US Patent 10034879 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
‌
US Patent 10077249 Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
‌
US Patent 10137118 Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
‌
US Patent 10450269 Compounds and uses thereof for the modulation of hemoglobin
‌
US Patent 10683285 Modulators of hemoglobin
Patent primary examiner
‌
Jean P Cornet

Find more entities like US Patent 11020382 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo